Poland invests in science

Research at the heart of the country's biggest ever investment plan

Written byJane Burgermeister
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

At a conference in Warsaw last week, EU Science and Research Commissioner Janez Potocnik warned that EU member states needed to do much more to support science.

Speaking on future EU research policy and opportunities, Potocnik said that European member states had worked hard to reach the goal of spending 3% of gross domestic product (GDP) on research, but he added that "action has not been sufficient yet for research investment to catch up more than marginally." Overall research and development (R&D) investment is now nearly 2% of GDP, up from 1.9% in 2002, he said—still a far cry from spending in the United States and Japan.

In Poland, the level of overall R&D investment in 2003 was 0.56% of GDP, Potocnik said. But his message did not fall on deaf ears. On January 11, the Polish government adopted an ambitious national investment plan that made science and the development ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform